education
|
points
Download App
Hong Kong
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Points
Download App
Country
Hong Kong
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
MIMS home
Drugs
Info
Panbesy
Panbesy
phentermine
Manufacturer:
Eurodrug
Distributor:
DCH Auriga - Healthcare
Concise Prescribing Info
Contents
Phentermine HCl
Indications/Uses
Anorexiant esp for treatment of conditions associated w/ excessive food intake. Adjuvant to dietary restriction.
Dosage/Direction for Use
15-30 mg daily.
Administration
Should be taken on an empty stomach: Take before breakfast. Avoid taking near bedtime. Swallow whole, do not chew/crush.
Contraindications
Epilepsy, hypersensitivity to sympathomimetic amines; advanced arteriosclerosis; severe HTN; hyperexcitability; CV disease, hyperthyroidism; glaucoma.
Special Precautions
Childn <12 yr; pregnancy & lactation.
Adverse Reactions
Dry mouth, restlessness, insomnia, headache, tremor, irritability, dizziness, increase in BP.
View
ADR Reporting Link
MIMS Class
Anti-Obesity Agents
ATC Classification
A08AA01 - phentermine ; Belongs to the class of centrally acting antiobesity products. Used in the treatment of obesity.
Regulatory Classification
DD, P
1
S
1
S
3
Presentation/Packing
Form
Panbesy nyscap 15 mg
Packing/Price
200's
Form
Panbesy nyscap 30 mg
Packing/Price
200's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Continue with Google
OR
Sign up with email
Already a member?
Sign in